Latest News and Press Releases

Alvotech (NASDAQ: ALVO) tilkynnti í dag að mannalyfjanefnd (CHMP) Lyfjastofnunar Evrópu (EMA) hafi mælt með því að veita markaðsleyfi fyrir AVT03, fyrirhugaða hliðstæðu Alvotech við líftæknilyfin...

REYKJAVIK, ICELAND (September 22, 2024) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today...

HYDERABAD, India and REYKJAVIK, Iceland, June 05, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines...

Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programsThe agreement includes proposed biosimilars to...

Columbia, MD, April 07, 2025 (GLOBE NEWSWIRE) -- Over 400 luminaries from government, industry, faith communities, and nonprofit sectors celebrated student scholars and the opening of the Kahlert...

REYKJAVIK, Iceland and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for...

Middletown, Connecticut, USA, Sept. 05, 2024 (GLOBE NEWSWIRE) -- (Middletown, Conn. September 5, 2024) – Liberty Bank, headquartered in Middletown, Connecticut, announced today that it is expanding...

EDMONTON, AB, Sept. 03, 2024 (GLOBE NEWSWIRE) -- All Weather Windows, a long-standing leader in the Western Canadian fenestration industry, is proud to announce that it is rebranding to All Weather...

SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...

BioCardia & StemCardia biotechnology company partnership targets heart failure, the leading cause of death and a condition with limited treatment options